Philippines FDA Updates Circular on Transition Period for Certificate of Medical Device Notification

The Philippines Food and Drug Administration (FDA) has issued FDA Circular No. 2021-002-B, an amended version of Circular No. 2021-002-A. …

read more...

Philippines FDA Publishes Update on Transfer or Refund of Payments 

The Philippines Food and Drug Administration (FDA) has issued FDA Circular No. 2021-027, which is the revised guidelines for the …

read more...

Philippines FDA Publishes Advisory on Abridged Route for ASEAN-Registered Medical Devices

The Philippines Food and Drug Administration (FDA) has issued Advisory No. 2021-3084, with details regarding the abridged route for the registration of medical devices …

read more...

Philippines FDA Issues Circular on Revised Post-Marketing Surveillance Requirements for New Drugs under Monitored Release

The Philippines Food and Drug Administration (FDA) has issued Circular No. 2021-020 to provide updated post-marketing surveillance (PMS) requirements for new drugs under monitored release, …

read more...

Philippines FDA Issues Circular on the Reference List of Class A Medical Devices

The Philippines Food and Drug Administration (FDA) has issued Circular No. 2021-017 on the 16th of August 2021, to guide manufacturers, importers, distributors, and other stakeholders in the medical device industry regarding the list …

read more...

Philippines FDA Issues Circular on Guidelines for the Transition Period for Medical Device to the ASEAN Harmonized Technical Requirements

This Circular issued on 9 August 2021 aims to provide guidelines for the transition period of medical devices covered by FC No. …

read more...

Philippines FDA Starts Pilot Implementation of eServices Portal System for Drug Products 

The Philippines FDA, in its commitment to provide stakeholders with streamlined and improved government services, is developing the FDA eServices …

read more...

Philippines FDA Issues Implementation Schedule and Guidelines on Standards for Medical Devices

The Philippines FDA issued Circular no. 2021-002 on 4th January 2021, which contains the implementation schedule of the Administrative Order …

read more...

Philippines FDA adopts the WHO Collaborative Registration Procedure (CRP) for the Accelerated Registration of WHO Prequalified Pharmaceutical Products and Vaccines.

This Administrative Order is issued to establish an accelerated review process for prequalified pharmaceutical products and vaccines, through the adoption …

read more...

More News